11. Allergic and immunologic diseases of the skin

Andrew Blauvelt, Samuel T Hwang, Mark C. Udey

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

Many skin diseases have an inflammatory or immune component, and anti-inflammatory drugs comprise a major portion of a dermatologist's therapeutic armamentarium. Although causes of most of these diseases remain obscure, mechanisms of lesion formation and explanations for symptoms are increasingly well documented. These developments, coupled with the expected availability of novel selective immunomodulatory agents, herald a new era for immunodermatology. Patients with psoriasis, allergic contact dermatitis, atopic dermatitis, urticaria, and autoantibody-mediated blistering diseases are among those who are likely to benefit from advances in the understanding of disease pathogenesis and the emergence of immunotherapeutics.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology
Volume111
Issue number2 SUPPL. 2
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Immune System Diseases
Skin
Allergic Contact Dermatitis
Urticaria
Atopic Dermatitis
Psoriasis
Skin Diseases
Autoantibodies
Anti-Inflammatory Agents
Pharmaceutical Preparations
Therapeutics

Keywords

  • Allergic contact dermatitis
  • Atopic dermatitis
  • Autoantibodies
  • Chemokines
  • Immunopathogenesis
  • Immunotherapeutics
  • Pemphigus
  • Psoriasis
  • Urticaria

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

11. Allergic and immunologic diseases of the skin. / Blauvelt, Andrew; Hwang, Samuel T; Udey, Mark C.

In: Journal of Allergy and Clinical Immunology, Vol. 111, No. 2 SUPPL. 2, 01.02.2003.

Research output: Contribution to journalReview article

Blauvelt, Andrew ; Hwang, Samuel T ; Udey, Mark C. / 11. Allergic and immunologic diseases of the skin. In: Journal of Allergy and Clinical Immunology. 2003 ; Vol. 111, No. 2 SUPPL. 2.
@article{c1236529ba88403c8cd893ec398e192a,
title = "11. Allergic and immunologic diseases of the skin",
abstract = "Many skin diseases have an inflammatory or immune component, and anti-inflammatory drugs comprise a major portion of a dermatologist's therapeutic armamentarium. Although causes of most of these diseases remain obscure, mechanisms of lesion formation and explanations for symptoms are increasingly well documented. These developments, coupled with the expected availability of novel selective immunomodulatory agents, herald a new era for immunodermatology. Patients with psoriasis, allergic contact dermatitis, atopic dermatitis, urticaria, and autoantibody-mediated blistering diseases are among those who are likely to benefit from advances in the understanding of disease pathogenesis and the emergence of immunotherapeutics.",
keywords = "Allergic contact dermatitis, Atopic dermatitis, Autoantibodies, Chemokines, Immunopathogenesis, Immunotherapeutics, Pemphigus, Psoriasis, Urticaria",
author = "Andrew Blauvelt and Hwang, {Samuel T} and Udey, {Mark C.}",
year = "2003",
month = "2",
day = "1",
language = "English (US)",
volume = "111",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2 SUPPL. 2",

}

TY - JOUR

T1 - 11. Allergic and immunologic diseases of the skin

AU - Blauvelt, Andrew

AU - Hwang, Samuel T

AU - Udey, Mark C.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Many skin diseases have an inflammatory or immune component, and anti-inflammatory drugs comprise a major portion of a dermatologist's therapeutic armamentarium. Although causes of most of these diseases remain obscure, mechanisms of lesion formation and explanations for symptoms are increasingly well documented. These developments, coupled with the expected availability of novel selective immunomodulatory agents, herald a new era for immunodermatology. Patients with psoriasis, allergic contact dermatitis, atopic dermatitis, urticaria, and autoantibody-mediated blistering diseases are among those who are likely to benefit from advances in the understanding of disease pathogenesis and the emergence of immunotherapeutics.

AB - Many skin diseases have an inflammatory or immune component, and anti-inflammatory drugs comprise a major portion of a dermatologist's therapeutic armamentarium. Although causes of most of these diseases remain obscure, mechanisms of lesion formation and explanations for symptoms are increasingly well documented. These developments, coupled with the expected availability of novel selective immunomodulatory agents, herald a new era for immunodermatology. Patients with psoriasis, allergic contact dermatitis, atopic dermatitis, urticaria, and autoantibody-mediated blistering diseases are among those who are likely to benefit from advances in the understanding of disease pathogenesis and the emergence of immunotherapeutics.

KW - Allergic contact dermatitis

KW - Atopic dermatitis

KW - Autoantibodies

KW - Chemokines

KW - Immunopathogenesis

KW - Immunotherapeutics

KW - Pemphigus

KW - Psoriasis

KW - Urticaria

UR - http://www.scopus.com/inward/record.url?scp=0037326199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037326199&partnerID=8YFLogxK

M3 - Review article

C2 - 12592302

AN - SCOPUS:0037326199

VL - 111

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2 SUPPL. 2

ER -